Universal Biosensors Inc (UBI) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 CORPORATE AVENUE
VICTORIA, 3178
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,32420,95525,97826,93331,55610,784
Cash and cash equivalents16,32420,95525,97826,93331,55610,784
Restricted cash and investments  5271,0981,5551,909
Receivables1,4641,4339747971,2171,260
Inventory, net of allowances, customer advances and progress billings3,7072,9863,1424,1602,3912,408
Inventory3,7072,9863,1424,1602,3912,408
Prepaid expense8471,2034905559051,084
Other current assets3759008257,4756,6325,751
Other undisclosed current assets5,8315,2644,736   
Total current assets:28,54832,74236,67241,01844,25723,196
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization545658616365
Operating lease, right-of-use asset4,1844,2804,4224,6854,8744,894
Property, plant and equipment4,7874,7404,5834,1093,6613,976
Intangible assets, net (including goodwill)   11,01511,42711,84012,248
Intangible assets, net (excluding goodwill)   11,01511,42711,84012,248
Restricted cash and investments320320320320320320
Other noncurrent assets928989919176
Other undisclosed noncurrent assets   (11,015)   
Total noncurrent assets:9,4379,4859,47320,69320,84921,578
TOTAL ASSETS:37,98642,22746,14561,71165,10644,774
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,2235,3056,1566,8004,9885,156
Employee-related liabilities773733641
Accounts payable1,252277268435284347
Accrued liabilities3,9715,0285,8885,5923,9714,168
Deferred revenue34423029429
Debt429779759231629
Business combination, contingent consideration, liability  2,2352,2142,3072,1772,005
Other liabilities  3,0523,0243,1512,9742,738
Other undisclosed current liabilities1,7701,6951,587748735694
Total current liabilities:7,45713,10813,08613,04411,11011,252
Noncurrent Liabilities
Long-term debt and lease obligation5153564,3414,5434,498
Long-term debt, excluding current maturities    6768 
Finance lease, liability515356586062
Liabilities, other than long-term debt6,6816,7496,8645,8685,8365,804
Asset retirement obligations3,0142,9672,9212,8172,7852,753
Deferred income tax liabilities    3,0513,0513,051
Operating lease, liability3,6673,7823,9444,2164,4154,435
Other undisclosed noncurrent liabilities614548364434
Total noncurrent liabilities:6,7946,8486,96810,24510,42310,335
Total liabilities:14,25119,95520,05423,28921,53221,587
Equity
Equity, attributable to parent, including:23,73422,27126,09138,42243,57423,187
Common stock212121212118
Additional paid in capital119,139119,090119,041118,965118,93293,816
Accumulated other comprehensive loss(357)(372)(292)(535)(376)(292)
Accumulated deficit(92,679)(92,679)(65,824)(65,824)(65,824)(65,824)
Other undisclosed equity, attributable to parent(2,390)(3,789)(26,855)(14,205)(9,179)(4,531)
Total equity:23,73422,27126,09138,42243,57423,187
TOTAL LIABILITIES AND EQUITY:37,98642,22746,14561,71165,10644,774

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues1,3041,2955,5946801,3611,723
Other income13 (44)11350
Cost of revenue
(Cost of Goods and Services Sold)
(491)(419)(276)(270)(535)(1,304)
Other undisclosed gross profit   (4,833)   
Gross profit:813877485410826419
Operating expenses(5,260)(5,394)(18,424)(6,178)(6,400)(6,031)
Operating loss:(4,447)(4,517)(17,939)(5,768)(5,574)(5,613)
Nonoperating income5,8457282,2387439261,082
Investment income, nonoperating186206209134345
Other nonoperating income5,1575333446936
Interest and debt expense      (1)
Income (loss) from continuing operations before equity method investments, income taxes:1,399(3,789)(15,701)(5,026)(4,648)(4,531)
Other undisclosed income from continuing operations before income taxes      1
Income (loss) from continuing operations before income taxes:1,399(3,789)(15,701)(5,026)(4,648)(4,531)
Other undisclosed income from continuing operations   3,051   
Income (loss) from continuing operations:1,399(3,789)(12,650)(5,026)(4,648)(4,531)
Loss before gain (loss) on sale of properties:(5,026)(4,648)(4,531)
Net income (loss) available to common stockholders, diluted:1,399(3,789)(12,650)(5,026)(4,648)(4,531)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):1,399(3,789)(12,650)(5,026)(4,648)(4,531)
Other comprehensive income (loss)15(80)244  31
Comprehensive income (loss):1,414(3,869)(12,406)(5,026)(4,648)(4,499)
Other undisclosed comprehensive loss, net of tax, attributable to parent    (160)(84) 
Comprehensive income (loss), net of tax, attributable to parent:1,414(3,869)(12,406)(5,185)(4,732)(4,499)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: